Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Vaccine makers Pfizer ‌and BioNTech have halted recruitment for a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment ​in the trials had been too low to generate ​the needed data.